Recent Investment Analysts’ Ratings Changes for Sotera Health (SHC)

Several brokerages have updated their recommendations and price targets on shares of Sotera Health (NASDAQ: SHC) in the last few weeks:

• 10/25/2026 – Sotera Health was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 10/23/2026 – Sotera Health was downgraded by Weiss Ratings from “buy (b-)” to “hold (c+)”.
• 10/17/2026 – Sotera Health was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 10/14/2026 – Sotera Health was downgraded by JPMorgan Chase & Co. from “neutral” to “underweight”. They now have a $17.00 price target on the stock.
• 10/8/2026 – Sotera Health was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 9/8/2026 – Sotera Health had its “overweight” rating reaffirmed by Piper Sandler. They now have a $25.00 price target on the stock.

Insider Activity

In related news, Chairman Michael B. Jr. Petras sold 850,000 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the transaction, the chairman owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. This represents a 17.64% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michael P. Rutz sold 150,000 shares of the firm’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the transaction, the insider directly owned 334,279 shares of the company’s stock, valued at approximately $6,297,816.36. This trade represents a 30.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 1,294,515 shares of company stock valued at $23,999,528. Company insiders own 15.36% of the company’s stock.

Sotera Health Company (NASDAQ: SHC) is a healthcare services company focused on sterilization, laboratory testing and infection prevention. Its services support manufacturers and providers across the medical device, pharmaceutical, tissue, food safety and other healthcare-related industries.

The company operates through three primary businesses. Sterigenics provides outsourced sterilization services, including ethylene oxide, gamma irradiation and electron-beam processing. Nelson Labs offers laboratory testing, analytical services and consulting for medical devices, pharmaceuticals and other healthcare products.